TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026

Rhea-AI Summary

TransMedics (Nasdaq:TMDX) will release its second quarter 2026 financial results after market close on Tuesday, August 4, 2026. Management will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT with phone and webcast access for investors.

News Market Reaction – TMDX

-4.16%

3 alerts

-4.16% Session close to close

$2.54B Market Cap

0.6x Rel. Volume

In the Jul 22 session, TMDX declined 4.16%, reflecting a moderate negative market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Prior earnings-date notices produced +4% and -4.3% reactions, a mixed platform record for this sched...

Analysis

Prior earnings-date notices produced +4% and -4.3% reactions, a mixed platform record for this scheduling event. The August 4 report can be viewed alongside moderate short positioning and one director sale, both relevant risk markers.

Key Figures

Reporting period: Second quarter 2026 Results release date: August 4, 2026 Conference call time: 4:30 p.m. ET +1 more

4 metrics

Reporting period Second quarter 2026 Financial results scheduled for release

Results release date August 4, 2026 After market close

Conference call time 4:30 p.m. ET Corresponding results conference call

Conference call time 1:30 p.m. PT Corresponding results conference call

Previous Earnings date Reports

2 past events · Latest: Apr 21 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 21	Earnings date	Neutral	+4.0%	Announced first-quarter 2026 results release date and conference call schedule.
Feb 10	Earnings date	Neutral	-4.3%	Announced fourth-quarter and full-year 2025 results release date and call schedule.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The two prior earnings-date notices produced opposite reactions of +4% and -4.3%, indicating no consistent directional pattern.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., July 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the second quarter 2026 after market close on Tuesday, August 4, 2026. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 6054544. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Gilmartin Group
Investors@transmedics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-second-quarter-2026-financial-results-on-august-4-2026-302831235.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics (TMDX) report its Q2 2026 earnings results?

TransMedics plans to report its Q2 2026 financial results after market close on Tuesday, August 4, 2026. According to TransMedics, the release will be followed by a management conference call the same afternoon.

What time is the TransMedics (TMDX) Q2 2026 earnings conference call?

The TransMedics Q2 2026 earnings call is scheduled for 4:30 p.m. ET / 1:30 p.m. PT on August 4, 2026. According to TransMedics, investors can join by phone or via a live webcast.

How can investors join the TransMedics (TMDX) Q2 2026 earnings call by phone?

Investors can join by dialing (800) 715-9871 domestically or (646) 307-1963 internationally and providing access code 6054544. According to TransMedics, these numbers connect directly to the live conference call.

Will there be a webcast of the TransMedics (TMDX) Q2 2026 earnings call?

Yes, a live and archived webcast will be available in the Investors section of the TransMedics website at https://investors.transmedics.com/. According to TransMedics, this offers online access for both real-time and replay listening.

Where can I find the replay of the TransMedics (TMDX) Q2 2026 earnings conference?

A replay will be accessible through an archived webcast on the TransMedics Investors webpage at https://investors.transmedics.com/. According to TransMedics, the archived version will be available after the live event concludes.